Atopic Dermatitis Patients’ Preference on Patient Self-administered Tools Used in Clinical Practice
DOI:
https://doi.org/10.2340/actadv.v103.5261Keywords:
Atopic dermatitis, Eczema, Quality of life, patient reported outcome measureAbstract
Abstract is missing (Short communication)
Downloads
References
Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet 2020; 396: 345-360.
https://doi.org/10.1016/S0140-6736(20)31286-1 DOI: https://doi.org/10.1016/S0140-6736(20)31286-1
Leshem YA, Chalmers JR, Apfelbacher C, Furue M, Gerbens LAA, Prinsen CAC, et al. Measuring atopic eczema symptoms in clinical practice: the first consensus statement from the Harmonizing Outcome Measures for Eczema in clinical practice initiative. J Am Acad Dermatol 2020; 82: 1181-1186.
https://doi.org/10.1016/j.jaad.2019.12.055 DOI: https://doi.org/10.1016/j.jaad.2019.12.055
Leshem YA, Chalmers JR, Apfelbacher C, Katoh N, Gerbens LAA, Schmitt J, et al. Measuring atopic eczema control and itch intensity in clinical practice: a consensus statement from the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) Initiative. JAMA Dermatol 2022; 158: 1429-1435.
https://doi.org/10.1001/jamadermatol.2022.4211 DOI: https://doi.org/10.1001/jamadermatol.2022.4211
Pariser DM, Simpson EL, Gadkari A, Bieber T, Margolis DJ, Brown M, et al. Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT). Curr Med Res Opin 2020; 36: 367-376.
https://doi.org/10.1080/03007995.2019.1699516 DOI: https://doi.org/10.1080/03007995.2019.1699516
Kido-Nakahara M, Yokote G, Yoshida M, Furue M, Nakahara T. Atopic dermatitis Control Tool (ADCT): a useful tool for self-evaluation in patients with atopic dermatitis. J Dermatol 2021; 48: 1951-1952.
https://doi.org/10.1111/1346-8138.16176 DOI: https://doi.org/10.1111/1346-8138.16176
Wei W, Anderson P, Gadkari A, Blackburn S, Moon R, Piercy J, et al., Discordance between physician- and patient-reported disease severity in adults with atopic dermatitis: a US cross-sectional survey. Am J Clin Dermatol 2017; 18: 825-835.
https://doi.org/10.1007/s40257-017-0284-y DOI: https://doi.org/10.1007/s40257-017-0284-y
Xu X, Olsson M, Bajpai R, Koh Jean Aan M, Weng Yew Y, Wong S, et al. Concordance between physician-rated and caregiver-perceived disease severity in children with atopic dermatitis: a cross-sectional study. Acta Derm Venereol 2020; 100: adv00308.
https://doi.org/10.2340/00015555-3540 DOI: https://doi.org/10.2340/00015555-3540
Maintz L, Bieber T, Bissonnette R, Jack C. Measuring atopic dermatitis disease severity: the potential for electronic tools to benefit clinical care. J Allergy Clin Immunol Pract 2021; 9: 1473-1486.e2.
https://doi.org/10.1016/j.jaip.2021.02.027 DOI: https://doi.org/10.1016/j.jaip.2021.02.027
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Johanna M. Mandelin, Anna Ekman, Suvi T. Ruohonen, Laura Korhonen
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
